Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited
Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 27/05/2011
PIL Baraclude 0.5 mg and 1.0 mg film coated tablets and Baraclude 0.05mg/ml oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to, or new, use for medicine
Updated on 04/03/2011 and displayed until 27/05/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/11/2010 and displayed until 04/03/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 27/09/2010 and displayed until 26/11/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 10/09/2010 and displayed until 27/09/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 28/08/2009 and displayed until 10/09/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Change to side-effects
Updated on 19/09/2008 and displayed until 28/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Introduction of new pack/pack size
Updated on 08/01/2008 and displayed until 19/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/06/2007 and displayed until 08/01/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/06/2007 and displayed until 05/06/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  entecavir